[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-INCY":3,"homepage-market-summary":31,"stock-news-INCY":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"INCY","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Incyte Genomics Inc","Nasdaq",null,"SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH","Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.","2,844","Wilmington, DE",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},114.13,115.145,115.67,112.83,115.3,-1.17,-1.01,1944434.597729,34303,113.9859,132.6,82.82,1847816.2113405617,62.9,8283,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},20,[176,182,187,193,199,205,211,216,222,228,233,238,242,247,252,257,262,266,271,276],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxPUEliMW5aTDFlaWRCc2NhRkVUN0JBc055UlEwUUs1M3doLUtLdDgxM19NUEs5bkI5ZTlSNVg5YzhHT2VhTmxYOFBqbjRJbS16OUhqeHAwcG84VElhMUN1M0lRb2VaRFNJM00zQWlYQWE4bU84NDZ5bUoyU3d3WVFWMjN6YXo1REZzSlJ0RGk1RzdmaW9mamc?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":179,"description":185,"source":186},"Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data Simply Wall Street","Simply Wall Street",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Incyte Stock Price Forecast. Should You Buy INCY? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE1OZHUydFhQVXBVeGlhM3hHQnUtVnNIVUM3UzZWRWRNSzBNajF2V2JzQkhOOFBTMTBLTnhuLThJQ2h1SXhzZF9sUA?oc=5","Fri, 25 Sep 2026 22:21:05 GMT","Incyte Stock Price Forecast. Should You Buy INCY? StockInvest.us","StockInvest.us",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"A legal chief with more than 25 years in pharma and biotech joins MiniMed. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxQU0l6c3VoZDRvNnZxV3FSMFktQUF1UjVoUEhXYXZoY3FPajN4cDJFeHRzcnVjMTUxbE80TUs2SUQ1WURqa2haQnE0bHBmc3Z2MHdDZ2tNdzBVQXBrMVhWZGxMNzhyMjI1TzJJeDllaF9URHYxV0lZN0VpWWVKSWVBSkxYSFpFV3Y3UEViVVluUTlYZ3ZYZGRTeHBhTURPSzh1YVhldDhMamVTYUQ4NUMta0t4QVVZZw?oc=5","Mon, 28 Sep 2026 13:03:00 GMT","A legal chief with more than 25 years in pharma and biotech joins MiniMed. Stock Titan","Stock Titan",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNdWRGZ3g5UTN1VUxwOU9LY1dUaUsxNkJ6N09ZWFF0a3FMZEhtR0RTakxRUHUtVWEwdnZtUlhrSmJORmFZU3NUdmprUFZwQk9mTkhhU29uckRqVGdmeDB2LTh4bFB0REVEb0p6OVRxdFg4M2F6QS1MOGpSa3J3el9jNkFPdVVzMWhjZXNlTGV4TFZsNFJjSGdKMTN1bmRpNFFqV0RESnRXQ0lnQTlwUlVzRWN1aGppZXQ4azNBTWpB?oc=5","Wed, 30 Sep 2026 11:41:22 GMT","Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup ChartMill","ChartMill",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQOG5ncFVmSjFxb0dlc0lwck9GUmdfeHlJakREZ25yU2NRcDdySzliUEJyTENBNUh0MFNtU3lVRW1obl9mckloamljMTAtRFM2SDZ3elh6amxrdWdmNXZvZXR0OUZTZU8wQnkyOXR3MGVweU4tXzM1NzRqNWFDYjRZSTctU2JoSVByRmpkR3pRTWJsOWxLWEplbndSOExoRndYZHNCc29WTE94S1Rud01Ick52c3Nmal96?oc=5","Thu, 01 Oct 2026 22:00:38 GMT","If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today Benzinga","Benzinga",{"title":212,"link":213,"pubDate":214,"description":215,"source":181},"How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxQY2FvT3BheFF0SHJJalJKX1NEZ3hEbHVieEhkd3BWbTVBTmxoYjA2M2NQb21tRE5oTVZmb2Y4czgwVDhjVTlOdVd2X29tM3pyVGh4NDQ5ZGVMVmM4aVFzX0ZrX1EwbmJfbkhZY2cxczAzYmp5TlhXLThqdVdCUkoyRmxRZkhwSWszMEdTWl82RWpGRUpzR1hnanN1Q202WFlPVHc?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? Yahoo Finance",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill - stocktwits.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxNM1BVMnhSZlNtZ1czT2R1WmdlanpCUy1SNlZDV3JFTlpIZTFramtpbWF4SmlWR1BCWWpubXh2dlAwWHhZbHRHanJVaVNmNkUxTFhBcmJ6bkpoa3hRYmE5SWdEQ2NENk5lUERTOWVMM1JKRWIxcC10Qm9sLWdrZEgzV3RmQjdObkUxZ3NhZ0JPWTFoZ3lHVS1VTzl5dmpSS0tvSThsZW5xMHZIbkpaaVFqNF9KcHlPRWxWVkFLcko2UjhvMnNrQ0gwbEZ2QWxVVVhYcmFqeXNB?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill stocktwits.com","stocktwits.com",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"INCY Maintained by HC Wainwright & Co. -- Price Target Raised to $152 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxPYnZ5cnV6ZEFIQ3NyNVBLdmJTel9WZUM4UkhaZVgyRW8tNGlKVmpoeE95emNlbDR3ZkdqTzJxSWtRSDBmRXIyMGZhUjN6MDJDdDZjRlk3V29iOEt3blNDeGIwN0U5YUI4RWJ4ak1zZmlST1RrTlQ2cF8wZHN5akVINF9TMXFLVGZCRTh4eTZXSHZhTjNRM0ViZWx4ZmVGVjNmMHZB?oc=5","Mon, 28 Sep 2026 13:36:41 GMT","INCY Maintained by HC Wainwright & Co. -- Price Target Raised to $152 GuruFocus","GuruFocus",{"title":229,"link":230,"pubDate":231,"description":232,"source":198},"Incyte will present research on eczema, vitiligo and painful skin conditions in Vienna - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxOckNITjZ3UXhlRWlUdklCeWJ1OW1HZHdfTl9udTZ5Z21fNlpHeTVVR1IzMFBncWRWY3V6dVRDNTZhbmZJVWdYa3cwcDVmMVJrR2szcDlUd21uVVM1T2ViMEo5aTh3THV1bnM1NW8wVzRZT1pXTlZfRkViVm5RVTR1YkZPeG5NOHlOTjVwNmtSakdTLU9YTXBuT3dRanhPX3AtNGZJcUhVanR1X252RDhfWmFfZGhHaGNBOTJlcV9n?oc=5","Tue, 22 Sep 2026 12:30:00 GMT","Incyte will present research on eczema, vitiligo and painful skin conditions in Vienna Stock Titan",{"title":234,"link":235,"pubDate":236,"description":237,"source":181},"INCY or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimAFBVV95cUxNYVRSMUJzVUZ5elBtN3J6bkdkdTFxQ2V1Nm5ZVVJWYWZ0dmZobEpXVUFWaTMyTU5keEpVTWJ1YmtpZENMSHZ3UFB6NzdnYW5CMXIxTWRSVEk1YWthVktLcndWV3U0d1UwUEVWY3FKYkRYNFRuN3NCcjIyQ2hwbzNfVTlCdnpTVlFXejJ4dnZUZklyTFltSFlhTw?oc=5","Wed, 30 Sep 2026 14:40:02 GMT","INCY or TECH: Which Is the Better Value Stock Right Now? Yahoo Finance",{"title":239,"link":240,"pubDate":179,"description":241,"source":198},"Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxNU2JtWkNOcVZYdXZEQ2wxemJWWlFvUFp3bllsZzE5bHJRUE9XeU5idjZrM3JzdkVIdmItOU9wSVhYQWpYOGdZLTU3bUJVbUtVTTBncnRjZnpvMmxHdWJzRkxwdnlQSjRKQ1pFMmVpS29pVkt5Qm9xZHNqUnp1aUFqelJpM1B6aFFxTUxBME0xR0d0VnN0MkFjVTl6aFQ1YUZlNm5rRml1M0c?oc=5","Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. Stock Titan",{"title":243,"link":244,"pubDate":245,"description":246,"source":198},"A $40,500 director retainer becomes 322 shares for Julian C. Baker at Incyte (INCY). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxNX2ZmTmRyMUpxNTdsN2Y5SjVEV0Q2cXhsWVlveWs1US0xOHJHZklPcFZ2ZmQ3TnQ3OVJNckh6UmF3TjJRblVMMVdvcXU4TWZhcFpaXzE2OG1vdFhLYzZzY3IxZm5PRExGOTRwWEFtRHhpakZIRVhxdm84aTJYS0JpNFgtYllyX2NnSng0LTUwNnN5UEtheEs2el9BYjZKMDIwcmZBUE82dG4?oc=5","Fri, 02 Oct 2026 21:55:01 GMT","A $40,500 director retainer becomes 322 shares for Julian C. Baker at Incyte (INCY). Stock Titan",{"title":248,"link":249,"pubDate":250,"description":251,"source":181},"Incyte (INCY) Heads To EADV With New Skin Disease Trial Data - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxQN2VrbExySm83d0hMa2RNcnVHdzZWaTVRV0liQlo1UDlvNXVfenl1LU9PTG5xamlHUTZEbVVkTXZIMVQyc2dRd2xzZ2x4Z2tMQ21Dckk2OUcyY3V1SldYRDFhYkRVYXRjT1NhQkNReUk2M1BXdnNaMWt4alVTZV9ERmU1Q2xuOXVWNDkxM3RxNnhkQQ?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Incyte (INCY) Heads To EADV With New Skin Disease Trial Data Yahoo Finance",{"title":253,"link":254,"pubDate":255,"description":256,"source":198},"203 shares replace director fees at Incyte (INCY), with the award fully vested. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxNSS00N2dISVhPR2NnOUx4TTlUbk9CbGl3RkRVb0dPZFdqU3ZSWWUtSEhkT3BvTjR1d0RzQVhMYS1OVlhiQ3ZYTTZLVGhhWTRETE43UWhYQnpWYThMQlFyTWZCZWUwMmRCVUhMV3FaZEVEa0lCNGdscWloZm1QdUNLNDl3NEhoZ2NDZXpwbHNnM2Y3ejJQb0ZkMVNnd3BYYVVXUWFwZ2VyTEo?oc=5","Fri, 02 Oct 2026 20:03:16 GMT","203 shares replace director fees at Incyte (INCY), with the award fully vested. Stock Titan",{"title":258,"link":259,"pubDate":260,"description":261,"source":181},"Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxQUW03RVJuTktZcGpaY2tyQkFGMFp0SW92OVEyVkFBMXpwS1VHZU9DSWJsNGpUMjZScXVrOVcxVnc1WGN3LVJyMkZMVmFaRlozeVpZVGhSbU1YYmdnUUVUUWlsbU12QU40VEtsZFNIdExKN0dZX1dheGNDLXZOS29Vb1pRWThfRXN4ejVlMU1WS2tBUDBOQ0dTbXRB?oc=5","Thu, 01 Oct 2026 19:33:07 GMT","Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment Yahoo Finance",{"title":263,"link":264,"pubDate":219,"description":265,"source":198},"About 300 people in the U.S. have a disease that causes bone to form in soft tissues. FDA approves a treatment. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxNNHJ2a2xFQTVreHo0bEMtRzdIdW1PeXdfX1VlbmRBUnFVRDNucXYyQm1qTEZYU0g1dTB4cWw2ak5LNk1QWkVTNWlsbnVubTZrSlB5SC11Y0lRZkh2bkU0anowb0xxN0ZRTkFrUWtiQnR6SndtV2s0UFpadnFKamlNcEw5bzA3ZTJqeEE4MzRwSnViWWI5eTJmQVg4empWYWRhb0hnVGFiVHE4aFBiX0xHVVFWZWRIcVE?oc=5","About 300 people in the U.S. have a disease that causes bone to form in soft tissues. FDA approves a treatment. Stock Titan",{"title":267,"link":268,"pubDate":269,"description":270,"source":198},"Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxNWWoydm5XOHo2bEZDNDRaS3dFQlc4MDlucF9kSlBVeWhOVWVzbFlhSlpZSlp2VmJhNFppelZHV0djX2owOVB6bVJGb0pFZDRJZE1pS1FtOWQyREZVYlRPSVQwTzBkeUxpa2xNNmNZalh3X2xwT3A2MnRuVVBtbk1qc3NIZW9tWG1IRGdMNzBOSmpTbGtJS3ZyWHB3MnVfeGNjcG5KWEtTRW0?oc=5","Fri, 02 Oct 2026 20:02:34 GMT","Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares. Stock Titan",{"title":272,"link":273,"pubDate":274,"description":275,"source":198},"463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxOUXV1ZGdlUjNYb0lvSGlRRlVJV0RkcWZKUk9MT010NjQySnlnZmFVRkhCR3ZnUUpJMXdlOW5ySWVOMk9TTUp1YkpDVnBjNUtHa0NKVE1RZG9zNVRaMmd2cHhPaEZGWjVuM0dFSGVhSF9FUFNEalA2T0tZQmhlaVd1ZzZSaVhvaF85dFh5cFFqVE9hdWJ6TnhuVDJQMnZvQllEdlFxQjk4OEc?oc=5","Mon, 05 Oct 2026 20:02:26 GMT","463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. Stock Titan",{"title":277,"link":278,"pubDate":279,"description":280,"source":186},"Incyte (INCY), What Is Behind The Fresh Attention? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxOWGg5QlBMbG9pb0hOZ2cyRXRhQkVralJqb3gxQXF2cjBLMlFPQjAtQUtsUHBMTnBwQk16aEd2Sld5b3NpaTlFc3ludGh6RG9jTEw4US10c1JnSHNBMmN5TU84a1dNd3JDZ0xYU2gwVlY4S0R4VnhkU01UWGtnMnJVUnBoZFZaU2hWb0YwVnB5d29YQTh5d0dPVjFKUXZabklPYS1vZmtWOXRRbjZYSGVoVmdGNEJ4RU0tYm9laXc5WFkxZkdZ0gHKAUFVX3lxTFBDM014U2c4cUt1V21aYmZJY0QwajNEUkdIQ2V6N3FqMjRqOVQzYzBWbV9HZW42bmlvSVB5QWNXME9qenFfZGFGQjd3M2hZeGpYaE1RV0dfTlN2NWVPZVRUVkJEdlRZYWFqU0JJcElfMG8xVlV3dW5IdzVxUGFlc05CX0tuQXVPbFFyUUY2TW96aUpDZS1vMTBuRmRTbHRfSXJwd1ZyV1Y5ZEN4bHlOQmNqRWd6RGI4UUJXdVJwMDQwaWF6NXFJVDd1cHc?oc=5","Tue, 29 Sep 2026 03:27:31 GMT","Incyte (INCY), What Is Behind The Fresh Attention? Simply Wall Street"]